Management of Patients With Chemotherapy–Induced Nausea and Vomiting
November 5, 2016
- Describe the various mechanisms of action for agents used to manage CINV (such as NK-1 and 5-HT3 receptor antagonists).
- Recall chemotherapy agents that are highly and moderately emetogenic.
- Demonstrate how APs should anticipate and prevent delayed CINV in cancer patients.
Gaylord National Hotel
National Harbor, MD
- 0.75 ACPE
- 0.75 AMA PRA Category 1 Credit(s)™
- 0.75 Attendance
- 0.75 ANCC